Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation

Brain Behavior and Immunity ◽

10.1016/j.bbi.2014.12.016 ◽

2015 ◽

Vol 47 ◽

pp. 193-200 ◽

Author(s):

Jeremy F. Weinberger ◽

Charles L. Raison ◽

David B. Rye ◽

Amy R. Montague ◽

Bobbi J. Woolwine ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Sleep Continuity ◽

Resistant Depression ◽

Necrosis Factor

Download Full-text

176. The tumor necrosis factor-alpha antagonist infliximab reduces depressive symptoms in patients with treatment resistant depression and high inflammation

Brain Behavior and Immunity ◽

10.1016/j.bbi.2012.07.200 ◽

2012 ◽

Vol 26 ◽

pp. S49

Author(s):

C. Raison ◽

R.E. Rutherford ◽

B. Woolwine ◽

C. Shuo ◽

P. Schettler ◽

...

Keyword(s):

Depressive Symptoms ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Resistant Depression ◽

Alpha Antagonist ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955710.793480389 ◽

2013 ◽

Author(s):

Carmine Pariante ◽

Valeria Mondelli

Keyword(s):

Tumor Necrosis ◽

Controlled Trial ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Tumor Necrosis Factor Antagonist ◽

Randomized Controlled ◽

Resistant Depression ◽

Factor Antagonist ◽

Necrosis Factor

Download Full-text

Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression

Brain Behavior and Immunity ◽

10.1016/j.bbi.2013.04.004 ◽

2013 ◽

Vol 31 ◽

pp. 205-215 ◽

Author(s):

Divya Mehta ◽

Charles L. Raison ◽

Bobbi J. Woolwine ◽

Ebrahim Haroon ◽

Elisabeth B. Binder ◽

...

Keyword(s):

Lipid Metabolism ◽

Tumor Necrosis ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Tumor Necrosis Factor Antagonist ◽

Glucose And Lipid Metabolism ◽

Resistant Depression ◽

Factor Antagonist ◽

Necrosis Factor ◽

Predict Treatment Response

Download Full-text

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

JAMA Psychiatry ◽

10.1001/2013.jamapsychiatry.4 ◽

2013 ◽

Vol 70 (1) ◽

pp. 31 ◽

Author(s):

Charles L. Raison ◽

Robin E. Rutherford ◽

Bobbi J. Woolwine ◽

Chen Shuo ◽

Pamela Schettler ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Tumor Necrosis ◽

Controlled Trial ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Tumor Necrosis Factor Antagonist ◽

Randomized Controlled ◽

Resistant Depression ◽

Factor Antagonist ◽

Necrosis Factor

Download Full-text

Elevated tumor necrosis factor-alpha receptor subtype 1 and the association with abnormal brain function in treatment-resistant depression

Journal of Affective Disorders ◽

10.1016/j.jad.2018.04.037 ◽

2018 ◽

Vol 235 ◽

pp. 250-256 ◽

Author(s):

Mao-Hsuan Huang ◽

Mu-Hong Chen ◽

Pei-Chi Tu ◽

Ya Mei Bai ◽

Tung-Ping Su ◽

...

Keyword(s):

Brain Function ◽

Tumor Necrosis ◽

Receptor Subtype ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Resistant Depression ◽

Abnormal Brain ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955710.793481436 ◽

2013 ◽

Author(s):

Filippo Drago ◽

Filippo Caraci

Keyword(s):

Tumor Necrosis ◽

Controlled Trial ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Tumor Necrosis Factor Antagonist ◽

Randomized Controlled ◽

Resistant Depression ◽

Factor Antagonist ◽

Necrosis Factor

Download Full-text

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Case Medical Research ◽

10.31525/ct1-nct04009668 ◽

2019 ◽

Author(s):

Keyword(s):

Tumor Necrosis Factor ◽

Focal Segmental Glomerulosclerosis ◽

Tumor Necrosis ◽

Minimal Change Disease ◽

Minimal Change ◽

Treatment Resistant ◽

Segmental Glomerulosclerosis ◽

Tumor Necrosis Factor Inhibition ◽

Necrosis Factor

Download Full-text

Tumor necrosis factor α (TNFα) potentialtes the ion secretion in mouse distal colon

Gastroenterology ◽

10.1016/s0016-5085(01)82636-6 ◽

2001 ◽

Vol 120 (5) ◽

pp. A531-A531

Author(s):

J OPRINS ◽

C BURG ◽

J GROOT

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Distal Colon ◽

Ion Secretion ◽

Factor Α ◽

Necrosis Factor

Download Full-text

Involvement of tumor necrosis factor αin intestinal epithelial cell proliferation following paneth cell destruction

Gastroenterology ◽

10.1016/s0016-5085(01)82487-2 ◽

2001 ◽

Vol 120 (5) ◽

pp. A501-A501

Author(s):

H SENO ◽

M SAWADA ◽

T KAYAHARA ◽

H FUKUZAWA ◽

Y FUJISAWA ◽

...

Keyword(s):

Cell Proliferation ◽

Tumor Necrosis Factor ◽

Epithelial Cell ◽

Tumor Necrosis ◽

Intestinal Epithelial Cell ◽

Paneth Cell ◽

Intestinal Epithelial ◽

Epithelial Cell Proliferation ◽

Cell Destruction ◽

Necrosis Factor

Download Full-text

Increased expression of tumor necrosis factor in peripheral blood memory CD4+ T cells of patients with Crohn's disease

Gastroenterology ◽

10.1016/s0016-5085(01)81574-2 ◽

2001 ◽

Vol 120 (5) ◽

pp. A317-A317

Author(s):

J DETENA ◽

L MANZANO ◽

J LEAL ◽

A PRIETO ◽

E ANTONIO ◽

...

Keyword(s):

T Cells ◽

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Peripheral Blood ◽

Cd4 T Cells ◽

Tumor Necrosis ◽

Memory Cd4 T Cells ◽

Necrosis Factor

Download Full-text